Literature DB >> 15643231

Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.

Surendra M Kumar1.   

Abstract

PURPOSE: In this study preoperative and postoperative transrectal ultrasound prostate volume was evaluated in patients undergoing photoselective vaporization of prostate using an 80 W potassium-titanyl-phosphate (KTP) laser (Greenlight PV Laser System, Laserscope, San Jose, California) for obstructive uropathy secondary to benign prostatic hyperplasia or carcinoma of the prostate.
MATERIALS AND METHODS: A total of 18 patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia (8) and carcinoma of the prostate (10) were treated with an 80 W quasicontinuous KTP laser. Preoperative and immediate postoperative treatment prostate volume measurements were recorded by transrectal ultrasound. The end point of treatment was complete vaporization of the obstructive adenoma to the level of the capsular fibers and the creation of an adequate transurethral resection-like prostatic cavity. KTP/532 laser energy was delivered by a side firing glass fiber through a 27Fr continuous flow resectoscope. Photoselective vaporization of the prostate using sterile water irrigation was performed with all patients under spinal anesthesia. Mean lasting time +/- SEM was 33.5 +/- 12 minutes (range 11 to 53).
RESULTS: Mean preoperative prostate volume +/- SEM was 53.2 +/- 24.7 ml (range 23.6 to 110), while mean postoperative prostate volume was decreased to 26.2 +/- 14.8 ml (range 8 to 58) during a mean followup of 2.8 +/- 2.3 months (range 1 to 10), resulting in a 51% mean decrease in prostate volume, as measured by transrectal ultrasound. There was no significant intraoperative bleeding and no change in serum sodium postoperatively. One patient sustained a small capsular perforation with persistent venous bleeding, which could not be controlled with KTP laser. Because of poor vision, the procedure was completed with electroresection. Complications included mild dysuria in 2 patients (11%) and mild hematuria longer than 2 weeks in duration in 4 (22%).
CONCLUSIONS: Photoselective prostate vaporization can effectively vaporize obstructive benign and malignant prostatic tissue, leading to a significant decrease in the total volume of the treated prostate (p = 0.000).

Entities:  

Mesh:

Year:  2005        PMID: 15643231     DOI: 10.1097/01.ju.0000150099.31289.d7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  [Treatment of specific complications of locally advanced prostate cancer].

Authors:  F C von Rundstedt; A S Brandt; D Lazica; M J Mathers; S Roth
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

2.  Impact of prostate volume on the efficacy of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate: a retrospective, short-term follow-up study on evaluating feasibility and safety.

Authors:  Ja Hyeon Ku; Soo Woong Kim; Jae-Seung Paick
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

Review 3.  Managing the local complications of locally advanced prostate cancer.

Authors:  Jason W Anast; Gerald L Andriole; Robert L Grubb
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

Review 4.  Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: when is the fuss worth it?

Authors:  Werner W Hochreiter; Roger M Müller
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

5.  The one year outcome after KTP laser vaporization of the prostate according to the calculated vaporized volume.

Authors:  Ja Hyeon Ku; Jeong Yeon Cho; Sung Yong Cho; Soo Woong Kim; Jae-Seung Paick
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

6.  Can 80 W KTP Laser Vaporization Effectively Relieve the Obstruction in Benign Prostatic Hyperplasia?: A Nonrandomized Trial.

Authors:  Deok Hyun Han; Seol Ho Choo; Jin Woo Chung; Jeong Hee Hong; Sung Won Lee
Journal:  World J Mens Health       Date:  2012-12-27       Impact factor: 5.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.